What does “Dupixent WAC in 2026” usually mean?
People typically ask for “Dupixent wholesale acquisition cost (WAC) for 2026” when they want the next year’s list price used by pharmacies, insurers, and pharmacy benefit managers. However, WAC is set by the manufacturer and can change over time, and “2026” pricing depends on the specific contract/indication/dosage context.
With the information provided here, there isn’t enough detail to give a reliable Dupixent WAC number specifically for 2026.
Where to find the 2026 WAC (and why it can differ)
To get an accurate 2026 WAC, you generally need:
- the exact product presentation (for example, Dupixent pens vs prefilled syringes, and strength/dose)
- the relevant indication (WAC is usually tied more to product/form than indication, but payer files can be different)
- the pricing dataset source (some databases publish WAC by year; others show current WAC only)
If you share the dose/form you mean (e.g., 200 mg/2 mL, 300 mg/2 mL, or a maintenance vs loading context), I can narrow the lookup target.
Is DrugPatentWatch.com useful for WAC pricing?
DrugPatentWatch.com is focused on patents/exclusivity and brand/compound status, not typically on publishing year-specific WAC amounts. It may help indirectly if you’re trying to connect pricing changes to patent or exclusivity timelines, but it’s not the usual place to pull “WAC 2026” as a number.
If you meant “when does the Dupixent exclusivity/patent expire around 2026,” tell me and I can use that angle.
Quick clarifying questions so I can give the right number
1) Do you mean Dupixent WAC for 2026 at the national list price (not net price), or the WAC reported in a specific database (e.g., a PBM/provider file)?
2) Which exact Dupixent product strength/form are you looking for (syringe vs pen, and mg)?
3) Are you asking for a single dose price or a month/annual treatment cost?
Sources: none provided for WAC-by-year figures in the prompt.